145 related articles for article (PubMed ID: 35259623)
21. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
23. Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status.
Valero C; Zanoni DK; Pillai A; Xu B; Katabi N; Ghossein RA; Ganly I; Morris LGT; Shah JP; Wong RJ; Patel SG
J Surg Oncol; 2021 Jan; 123(1):141-148. PubMed ID: 32974936
[TBL] [Abstract][Full Text] [Related]
24. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI
Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study.
Nakashima H; Matsuoka Y; Yoshida R; Nagata M; Hirosue A; Kawahara K; Sakata J; Arita H; Hiraki A; Nakayama H
BMC Cancer; 2016 Jan; 16():41. PubMed ID: 26812901
[TBL] [Abstract][Full Text] [Related]
26. [Neutrophil-to-Lymphocyte Ratio(NLR)as a Predictive Indicator of the Response to Nivolumab in Patients with Oral Squamous Cell Carcinoma].
Tachinami H; Tomihara K; Ikeda A; Sekido K; Sakurai K; Imaue S; Fujiwara K; Hayashi R; Noguchi M
Gan To Kagaku Ryoho; 2021 Dec; 48(12):1485-1490. PubMed ID: 34911916
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.
Id Said B; Ailles L; Karamboulas C; Meens J; Huang SH; Xu W; Keshavarzi S; Bratman SV; Cho BCJ; Giuliani M; Hahn E; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; de Almeida JR; Chepeha DB; Irish JC; Goldstein DP; Hope A; Hosni A
JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):342-349. PubMed ID: 35238880
[TBL] [Abstract][Full Text] [Related]
28. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
29. Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival.
Harris JA; Hunter WP; Hanna GJ; Treister NS; Menon RS
Oral Oncol; 2020 Dec; 111():105037. PubMed ID: 33096312
[TBL] [Abstract][Full Text] [Related]
30. Statistical profiling of oral cancer and the prediction of outcome.
Wang W; Adeoye J; Thomson P; Choi SW
J Oral Pathol Med; 2021 Jan; 50(1):39-46. PubMed ID: 32939835
[TBL] [Abstract][Full Text] [Related]
31. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
[TBL] [Abstract][Full Text] [Related]
32. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.
Rock LD; Rosin MP; Zhang L; Chan B; Shariati B; Laronde DM
Oral Oncol; 2018 Mar; 78():119-125. PubMed ID: 29496039
[TBL] [Abstract][Full Text] [Related]
33. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
[TBL] [Abstract][Full Text] [Related]
34. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.
Sano Y; Kogashiwa Y; Araki R; Enoki Y; Ikeda T; Yoda T; Nakahira M; Sugasawa M
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):667-676. PubMed ID: 29359615
[TBL] [Abstract][Full Text] [Related]
36. Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
Hu Q; Peng J; Chen X; Li H; Song M; Cheng B; Wu T
Oral Oncol; 2019 Feb; 89():14-22. PubMed ID: 30732952
[TBL] [Abstract][Full Text] [Related]
37. Oral premalignant lesions of smokers and non-smokers show similar carcinogenic pathways and outcomes. A clinicopathological and molecular comparative analysis.
de la Oliva J; Larque AB; Marti C; Bodalo-Torruella M; Nonell L; Nadal A; Castillo P; Sieira R; Ferrer A; Garcia-Diez E; Alos L
J Oral Pathol Med; 2021 Mar; 50(3):280-286. PubMed ID: 31006144
[TBL] [Abstract][Full Text] [Related]
38. Surgery for maxillary oral squamous cell carcinoma: the effect of surgical resection margins and elective neck dissection on oncological outcomes.
Woo S; DeAngelis A; Koo K; Kranz S; Nastri A; Iseli TA; Fua T; Wiesenfeld D
Int J Oral Maxillofac Surg; 2023 Mar; 52(3):283-290. PubMed ID: 35851181
[TBL] [Abstract][Full Text] [Related]
39. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
40. Are Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma?
Jariod-Ferrer ÚM; Arbones-Mainar JM; Gavin-Clavero MA; Simón-Sanz MV; Moral-Saez I; Cisneros-Gimeno AI; Martinez-Trufero J
J Oral Maxillofac Surg; 2019 Sep; 77(9):1906-1914. PubMed ID: 30980811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
